Blister pack with dollars instead of pills on Aug. 26, the Department of Health and Human Services released new guidance stating the cost-sharing rule, which would have gone into effect next year, will not be enforced. (Photo: Shutterstock)

Federal health care officials have made clear they do not believe pharmaceutical companies that provide coupons to customers are helping to make prescription drugs more affordable. However, the Trump administration hasn't quite figured out yet what to do about it.

Like insurers and pharmacy benefits managers, some of which have sought to undermine the practice with accumulator adjustment programs, the Trump administration believes such coupons may be driving up health care spending by getting patients to opt for higher-priced name-brand drugs over generics.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Health Care Reform
Employee-Paid